MedPath

Optimization of the respiration phase regarding the effects of respiratory motion on LET distribution in abdominal and pelvic carbon radiation therapy

Not Applicable
Recruiting
Conditions
abdominal and pelvic sarcoma
Registration Number
JPRN-UMIN000052173
Lead Sponsor
ational Institute of Quantum Science and Technology
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
20
Inclusion Criteria

Not provided

Exclusion Criteria

1) Those whose heavy ion radiotherapy was discontinued for some reason after consent was obtained. 2) Persons in whom an unexpected abnormality was found in a test conducted after consent was obtained. 3) Persons who have difficulty performing the two types of CT scans due to cognitive impairment. 4) Persons with metal implants that affect treatment planning CT. 5) Other persons who are judged to be ineligible as research subjects by a doctor who is a researcher, etc.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To calculate the dose distribution and LET distribution in the phase used for irradiation and evaluate the influence of respiratory movement on DVHs and LET distributions of tumors, and organs at risk.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath